Comparison between Ganga Pharmaceuticals IPO and Sylph Education Solutions IPO.
Ganga Pharmaceuticals IPO is a SME Fixed Price IPO proposed to list at BSE SME while Sylph Education Solutions IPO is a SME Fixed Price proposed to list at BSE SME.
| Ganga Pharmaceuticals IPO | Sylph Education Solutions IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | First Overseas Capital Ltd. | Corporate Strategic Allianz Ltd. |
| Registrar | Kfin Technologies Ltd. | Purva Sharegistry (India) Pvt.Ltd. |
| Market Maker | Alacrity Securities Ltd. | NNM Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Ganga Pharmaceuticals IPO is up to ₹1.54 Cr whereas the issue size of the Sylph Education Solutions IPO is up to ₹4.56 Cr. The final issue price of Ganga Pharmaceuticals IPO is ₹15.00 per share and of Sylph Education Solutions IPO is ₹12.00 per share.
| Ganga Pharmaceuticals IPO | Sylph Education Solutions IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹15.00 per share | ₹12.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 8000 shares | 10000 shares |
| Fresh Issue Size | 10,24,000 shares | 38,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹1.54 Cr | up to ₹4.56 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 10,24,000 shares | 38,00,000 shares |
| Issue Size Total (Amount) | up to ₹1.54 Cr | up to ₹4.56 Cr |
Ganga Pharmaceuticals IPO opens on Jan 29, 2016, while Sylph Education Solutions IPO opens on Feb 10, 2016. The closing date of Ganga Pharmaceuticals IPO and Sylph Education Solutions IPO is Feb 09, 2016, and Feb 15, 2016, respectively.
| Ganga Pharmaceuticals IPO | Sylph Education Solutions IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 29, 2016 | Feb 10, 2016 |
| Issue Close | Feb 09, 2016 | Feb 15, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Feb 22, 2016 | Feb 23, 2016 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Ganga Pharmaceuticals IPO P/E ratio is , as compared to Sylph Education Solutions IPO P/E ratio of .
| Ganga Pharmaceuticals IPO | Sylph Education Solutions IPO | |
|---|---|---|
| Financials | ||
| Promoter Shareholding (Pre-Issue) | 91.05 | |
| Promoter Shareholding (Post-Issue) | 68.09 | |
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW | 1.27% |
In the Ganga Pharmaceuticals IPO Retail Individual Investors (RII) are offered 5,12,000 shares while in Sylph Education Solutions IPO retail investors are offered 5,12,000 shares. Qualified Institutional Buyers (QIB) are offered in Ganga Pharmaceuticals IPO and in Sylph Education Solutions IPO.
| Ganga Pharmaceuticals IPO | Sylph Education Solutions IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 0 shares | 2,00,000 shares |
| QIB | ||
| NII | 5,12,000 shares | 19,00,000 shares |
| RII | 5,12,000 shares | 19,00,000 shares |
| Employee | ||
| Others | ||
| Total | 10,24,000 shares | 38,00,000 shares |
Ganga Pharmaceuticals IPO subscribed in total, whereas Sylph Education Solutions IPO subscribed .
| Ganga Pharmaceuticals IPO | Sylph Education Solutions IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
